Sort   by:  
 Page size 
ProteomicsNCLX proximity biotinylation screen
The mitochondrial sodium/calcium exchanger, NCLX, is critical to maintaining mitochondrial calcium homeostasis, yet little remains known about the mechanisms regulating its function. Here, we performed proximity biotinylation screening to identify the NCLX interactome and potential protein regulator...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000093004 | MassIVE
UnknownRelationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.
Not available
S-EPMC5303646 | biostudies-literature
UnknownEffect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Not available
S-EPMC4249701 | biostudies-literature
Genomicsena-DATASET-BTRC-03-04-2014-18:00:02:250-43 - samples
Whole genome alignments of DIPG patients
EGAD00001000814 | EGA
Genomicsena-DATASET-BTRC-26-04-2017-20:29:35:774-41 - samples
Diffuse Intrinsic Pontine Glioma (DIPG) is a fatal brain cancer that arises in the brainstem of children with no effective treatment. To understand what drives DIPGs we integrated whole-genome-sequencing with methylation, expression and copy-number profiling.
EGAD00001003305 | EGA
GenomicsWhole genome sequencing and whole exome sequencing of DIPG tumors and matched normal tissue
Diffuse Intrinsic Pontine Glioma (DIPG) is a fatal brain cancer that arises in the brainstem of children with no effective treatment. To understand what drives DIPGs we integrated whole-genome-sequencing with methylation, expression and copy-number profiling.
EGAS00001000575 | EGA
GenomicsBTRC Data Access Committee
Data Access Committee EGAC00001000149
EGAC00001000149 | EGA
GenomicsEGAD00000000119
Genotypes from cell lines derived from breast carcinoma tissue
EGAD00000000119 | EGA
GenomicsAssessment of genomic copy number alterations in breast cancer
The aim of this study was to assess genomic copy number alterations in a panel of breast cancer cell lines. These data were used to identify common aberrations associated with breast cancer, and also to identify aberrations associated with response to therapeutic compounds.
EGAS00000000059 | EGA
GenomicsBreast Cancer Cell Line Data Access Committee
Access to data is available by emailing application to the data access committee and will be granted to qualified investigators for appropriate use.
EGAC00000000015 | EGA
Sort   by:  
 Page size